Cobimetinib for BRAF-wild-type or Mutated Histiocytoses

Clinical trial NCT04007848 · COMPLETED

Trial details

NCT number: NCT04007848
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Disease or R Group Histiocytoses

Start date: 2019-07-25
Primary completion: 2021-10-05
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.